An integrated system for immunomagnetic separation of rare cells from blood is presented. A micromachined device was fabricated by bonding silicon die with etched structures to a glass cover plate on which electrodes are defined. Electrolytic generation of gas from 0.50 M KNO 3 (aqueous) provided pumping actuation for a device that performed the capture and purification of rare cells spiked into a 7.5 µl reconstituted blood sample. The system consisted of two pumps, a sample and a wash buffer meander reservoir, and a main channel for magnetic field trapping of rare cells captured by antibody-coated magnetic beads. A maximum pumping rate of 1.4 ± 0.1 µl min −1 was obtained at a current of 180 µA, and the maximum blood sample volume delivered to the capture bed was 6.5-7 µl. The trapped cells could be washed with the buffer from the second pump and then delivered to the exit port of the chip after removing the magnetic field.
Introduction
The preparation of biological samples for analyses such as immunoassays or genetic assays within microfluidic devices would greatly contribute to the automation of analytical procedures, yet it remains a significant challenge. The relatively large volumes of sample that are required to minimize sampling error for low concentrations of a pathogen mean that electrokinetic pumping methods do not have the required capacity.
While a variety of designs of mechanical micropumps with higher capacity have been tested [1] [2] [3] , the most widespread approach uses a diaphragm actuated by means of electrostatic, piezoelectric, or thermal expansion mechanisms. The fabrication of membrane-or diaphragm-based pumps is often complex, involving many photolithographic steps. The complexity makes the cost high for use with biological sample preparation, which often requires single-use, disposable components. Further, very few of those pumps have been tested with biological fluids, and we have found no reports of blood samples being mobilized with a micropump. Since pumping blood is much more challenging than most fluids, this remains a significant test for a micropump.
Electrochemical production of gas bubbles by electrolyzing water provides an actuation mechanism that can deliver high displacement volumes relative to the size of the device. The electrolysis of water to actuate a diaphragm has been described and used in several applications [4, 5] . For example, a wrist-worn infusion pump has been developed for a drug delivery system [6] , and electrolysis was used to provide a H 2 /O 2 gas mixture to feed a flame ionization detector [7] . Recently, a group at the University of Twente [8, 9] described a microfabricated electrochemical pump, in which gas formed by electrolysis of a solvent forms a bubble pump. Low voltages were applied to a sample electrolyte solution located in the pump chamber in order to pump sample loaded in a meander attached to the pump chamber. Flow rates up to 2 µl min −1 were achieved [8] . The device fabrication process required only two mask steps, and could ultimately be adapted to low-cost fabrication in plastic.
Here we describe the adaptation of the Twente electrolysis micropump to the manipulation and initial processing of a blood sample. Our goal was a device that would deliver blood to a processing zone on chip where rare cells could be captured, and purified by washing away the remaining blood components, followed by delivery of the isolated cells from the chip for analysis. Immunomagnetic cell separation methods [10] [11] [12] were used to trap cells inside the micro-flow channels [13] . Rare cells were captured on antibody-coated magnetic beads [14, 15] , which were then trapped by a magnetic field in a region within the chip. A pair of electrolysis chambers was designed to work in a stepwise fashion to first deliver blood, and then the wash buffer needed to purify the rare cells. As described in this report, to accomplish these goals we increased the electrolysis chamber and the sample meander capacity from 1.5 to 7.5 µl. The initial Twente design was difficult to fill, allowing the introduction of only one liquid, and so we also developed a system of access holes for the device along with a procedure that greatly eases filling. Successful testing of the design with reconstituted horse blood samples has shown that it could ultimately serve as the first stage of a more complex analytical system, providing the initial sample clean-up stage required by a micro total analysis system (µ-TAS) for clinical diagnostic applications.
Experimental section

Fabrication
The reservoirs, channels and chevrons of the design shown in figure 1 were etched on a silicon wafer (400 µm thick) to a nominal depth of 100 µm using deep reactive ion etching (DRIE A 25 nm thick titanium adhesion layer was sputtered (Leskar, magnetron system) on a Schott borofloat glass wafer, followed by a 150 nm thick platinum layer. The glass was cleaned in piranha (3:1 mixture of H 2 SO 4 :H 2 O 2 ) for 15 min, then rinsed in nanopure water. The electrodes were patterned by photolithography using positive HPR 504 photoresist (Arch Chem., Norwalk, CT, USA) and a lift-off process. The wafer was sonicated in acetone for 6-8 h to obtain liftoff. Annealing the glass cover plates after patterning the Ti/Pt electrodes was required to prevent electrode delamination in the first 30 min of use. Each electrode area was 9.83 mm 2 . Anodic bonding of glass to Si was performed on diced dies using 1000-1500 V, at 300-400
• C [9] . Complete bonding required 10 to 15 min. Contact wires were glued onto the bonding pads using a conductive epoxy (Chemtronics, Kennesaw, GA, USA). Epoxy glue was applied where the metal leads passed out of the electrolysis chambers, to prevent any leakage due to poor bonding over the top of the electrodes.
Operation and measurement procedures
Devices were filled with three different liquids in sequence using a syringe pump or a 10 µl micropipet with a 'gelloading' micro-capillary tip (OD = 0.61 mm, cat. no F103-10, Rose Scientific Ltd, Edmonton, AB, Canada). The numbering of the access holes and the filling sequence is shown in figure 2 . Insulating tape (Scotch Super 33 vinyl electrical tape, 3M, USA) was used to temporarily seal various holes during filling. When using a syringe pump the electrolysis pump chambers were filled with 0.50 M KNO 3 , infused at 100 µl min −1 into the first chamber through access hole 3, with holes 1, 2, 5, 6 and 7 sealed, and then through hole 6, with holes 1, 2, 3, 4 and 5 sealed. Hole 7 was then sealed, and hole 5 was opened to infuse 40 µl of Dulbecco's phosphate-buffered saline 14190 (1×) (PBS) buffer (Life Tech., Rockville, MD, USA) through hole 6 at 50 µl min −1 . Holes 5 and 6 were then sealed and holes 2 and 3 were opened to allow delivery of reconstituted horse blood through hole 3 at 50 µl min −1 . All the holes were then kept sealed until access hole 1 was opened at the start of the experiment. When using a micropipet the same filling sequence was employed, but 10 µl was delivered at each step.
Reconstituted horse blood samples were prepared containing 5.5 × 10 5 Jurkat cells ml −1 and 1.0 × 10 10 horse red blood cells ml −1 (1:18 200 ratio of Jurkat cells to horse red blood cells) in 1:1 horse plasma to RPMI media 1640 (Roswell Park Memorial Institute). Before mixing, the cells were counted with a hemacytometer (Sigma-Aldrich, Oakville, ON, Canada). (The total cell concentration is similar to a blood sample, so the physical properties of the reconstituted blood, e.g. viscosity, are comparable to those of blood.) Jurkat cells (ATCC No TIB 152, an immortalized human T-cell line) were prepared according to the supplier's (ATCC) instructions. Anti-human CD3 (BD PharMingen Canada, Mississauga, ON) was loaded onto 1-2 µm diameter paramagnetic beads by mixing 100 µl of Protein A paramagnetic particle suspension (13.3 mg solid ml −1 suspension, with 100 µg Protein A ml of suspension, Polysciences, Warrington, PA, USA) with 1000 µl of 40 µg ml −1 anti-human CD3 in an Eppendorf tube. Particles were pelleted with a magnetic field and washed three times with PBS to remove unbound anti-CD3. The particles were resuspended in 99 µl PBS and 1 µl of this suspension was mixed with 500 µl reconstituted blood.
For pump operation a Hewlett Packard power supply (Model 6215A) provided constant voltage, while an RDE4 potentiostat/galvanostat (Pine Instrument, Grove City, PA, USA) was used to apply constant current. A 6 mm diameter NdFeB permanent magnet (Edmund, Ind. Optics, Barrington, NJ, USA) was used to create the magnetic field for bead trapping on the chip. To visualize gas production and pumping, a CCD camera (JVC, Model TK-1280U) attached to a BH-2 Olympus microscope with a 5× power objective was used. Displacement of liquid was viewed on a video monitor. The time for the liquid front to travel a distance of 0.2-1.0 mm along the main channel was measured using a stopwatch. The distance was measured using a scale that was prepared on the mask pattern and fabricated on the device beside the channel, as illustrated in a photo (see figure 7) . The nominal cross section of the channel and the distance traveled were used to calculate the volumetric flow rate. The absolute volume flow rates in any given device differed by up to +10% from the nominal values reported, due to variations in dimensions of the channels from chip to chip. PCR primers (V1, TACATCCACTGGTACCTACACCA, J1/2, CCCGTCGACTACCTTGGAAATGTTGT ATTCTTC [16] ), a T-cell-specific receptor γ gene, and DNA marker ( X174 RF DNA/Hae III fragments) were obtained from Invitrogen (Burlington, ON, Canada). Tris-(hydroxymethyl)-aminomethane base solution, EDTA, and boric acid for running buffer (TBE) were purchased from Amersham Biosciences (Baie d'Urfé, QC, Canada). Ethidium bromide homodimer, used to stain DNA, was obtained from Molecular Probes (Eugene, OR, USA). The Dynabeads DNA DIRECT TM kit was purchased from Dynal Biotech (Lake Success, NY, USA) and the PCR kit (GeneAmp PCR Core Reagents) from Applied Biosystems (Foster City, CA, USA).
Beads with captured cells were collected from outlet 1, lysed, and the DNA captured on Dynabeads during a brief incubation as specified in Dynal's protocol. The DNA/Dynabeads were placed in a 20 µl resuspension buffer, and the T-cell gene was amplified by PCR, using a Progene Techne thermal cycler (Mandel Scientific Company Ltd, Guelph, ON, Canada).
A 300 bp product was obtained following a published procedure [16] . Capillary gel electrophoresis (CGE) was performed using a Beckman P/ACE 5010 equipped with a 488 nm laser module LIF detector, 580DF40 (Omega Optical) filter and 488 nm notch filter. A 27 cm long, 50 µm i.d. fused silica capillary was filled with TBE running buffer, containing 0.4% HPMC and 0.5 µg ml −1 ethidium bromide. After a 5 kV, 5 s sample injection, the Beckman P/ACE 5010 system was operated at 5 kV to detect the PCR product.
Results and discussion
Design and filling of capture system
Two electrolysis pumps were integrated side by side, attached to the same flow manifold, to use one for the pumping sample, and the other to pump a wash fluid. Figure 1 shows the device layout. Inter-digitated electrodes are located in the electrolysis chambers, and a chevron of Si barriers separates the anolyte and catholyte compartments, in order to reduce mixing of the gases produced. A long meander is present downstream of the pumps to provide sample or buffer reservoirs. While similar to the Twente design [8] , the device differs in a number of aspects. It is about three times larger in width and length, and holds about 7.5 µl of electrolyte in the pumping chambers. A number of additional inlet and outlet holes were added to ease the filling of these devices. Additionally, the pump chambers were rounded at the corners to reduce the tendency to trap air bubbles during filling. As shown in figure 3 , the chevron structure at the entrance to the electrolysis chambers was positioned to partition 2/3 of the liquid toward the larger H 2 chamber and 1/3 through the smaller O 2 chamber, to reduce the tendency to trap bubbles during filling.
The original Twente design, with a single access port, was filled by placing the device in an evacuated chamber, with liquid over the port, and then returning the chamber to atmospheric pressure. This procedure is inconvenient, does not allow for flushing if bubbles form in the device, and means that the sample liquid is the only one that can be introduced. Detail of the layout of the chevron barrier used to reduce gas mixing between the anolyte and catholyte compartments, and the inlet to the electrolysis chamber from access hole 3.
The access hole pattern we have introduced readily allows the ingress of separate background electrolyte, sample and wash buffers. Figure 2 and the experimental section give the filling procedure, which is simple to perform. The device can be filled manually with a pipet in less than 4 min, or with a syringe pump. Steps 1-3 in figure 2 can be performed in advance, and the device may then be sealed and stored for several days before the blood sample is introduced at the time of use. Adding the blood sample from a pipet and re-sealing the device requires less than 1 min. These changes in inlet design created a device that could be filled in a flexible fashion, allowing the pump fluid to be different from the sample fluid. Further, the ability to introduce a separate wash fluid in one of the meanders is a crucial element in creating a system for sample processing that can perform both a capture and a subsequent wash step.
Pump performance
The pump rate in the device was proportional to the applied current, as expected [8] . A sequence of flow rates as a function of current could be easily measured for a single charge of buffer solution when the current was kept below 90 µA. Figure 4 shows this dependence for a pump filled with 0.5 M KNO 3 . The response of flow rate to current density was 0.078 µl min −1 per µA mm −2 for the current range shown in figure 4 , compared to 0.049 µl min −1 per µA mm −2 in the smaller Twente devices [8] . The maximum flow rate obtained was 1.4 ± 0.1 µl min −1 at a current of 180 µA, but this rate consumed the electrolyte solution too rapidly to obtain a series of flow rate values at different (high) currents. Figure 4 shows that not all the current was used to produce H 2 and O 2 gases, since flow was achieved only after applying more than 20 µA. This current was observed in a dry device also, indicating the wet thermal oxide grown to passivate the silicon surface was not effective. The Twente device used a 250 nm thick oxide versus the 200 nm thick layer used here, indicating that the wet oxidation process used in this study did not produce an oxide of sufficient quality. The flow rate was also evaluated using various constant applied voltages in order to evaluate the compliance voltage required to achieve a given pump rate. The pumping performance of the device was tested with reconstituted blood samples and with PBS. Reconstituted horse blood was spiked with a known amount of Jurkat cells, a human-derived T-cell line, to provide a target that could be captured [17] by the anti-CD3-coated magnetic bead particles. Reconstituted blood was free of endogenous leukocytes, which attack the Jurkat cells and change their concentration over time. Figure 5 shows that voltages of 2.7-3.7 V were required for pump rates of ∼0.2-1.4 µl min −1 . Corresponding currents ranged from 30 to 200 µA. The flow rate obtained for pumping blood was slightly lower than that for pumping PBS buffer, at the same applied potential. This is consistent with the much greater viscosity of blood (51 ± 13 mPa s) [18] compared to PBS buffer (∼1.3 mPa s) [19] , requiring that a higher backpressure be developed in the pump chamber. Flow rates were determined for periods of 2.5 to ∼15 s, depending on the rate, and currents were stable for each measurement period. A maximum of 6.5-7 µl of blood could be delivered from the sample meander reservoir. However, once the gas bubbles in the electrolysis S167 chamber exceeded ∼60% of the volume, large fluctuations in the current and the flow were observed. Care was taken not to exceed 60% for the data reported. The variation in current between measurements was ±3-5% (rsd, n = 3-6) for PBS and ±10% for reconstituted blood. While the errors in current did not increase with voltage, figure 5 shows that there was some increased variation in the pump rate from run to run at higher voltages.
The results established that blood could be pumped with high precision by the electrolysis pump at flow rates 0.5 µl min −1 . For a batch-processing system such as this the fluctuations in flow rate at >1.2 µl min −1 would not create any difficulties in an analysis. Thus the pump works for its intended batch delivery purpose at all the flow rates tested. While a small amount of mixing of blood and electrolysis buffer occurred at access holes 3 and 6, the ingress of some blood constituents into the electrolysis chamber did not significantly affect the pumping ability. Blood samples are known to be challenging to pump [20] . The few reports of cells pumped with a micropump are performed at ∼10 6 cells ml
or less [21] , much below the value of 0.5 × 10 10 cells ml
in whole blood, or our reconstituted blood sample. Thus, our result is an important milestone along the road to creating a µ-TAS for clinical samples.
Rare cell capture system
The ability of the design to deliver a sample, trap magnetic beads in the main flow path, and then deliver a wash buffer to remove the blood constituents not trapped by the beads was then tested. Samples of reconstituted blood were mixed with magnetic, anti-CD3-coated beads and delivered into the sample meander reservoir. The electrolysis pump was then used to pump blood through the magnetic bead-trapping zone in the main channel at various flow rates between 0.05 and 0.5 µl min −1 . After delivering 2-3 µl of blood from the sample meander the sample pump was turned off and the same voltage was applied to the wash buffer pump. Visual observation showed that the blood was washed away, leaving Jurkat cells bound to magnetic particles trapped within the main flow path. Figure 6 shows a sequence of video images of the region where the two flows, blood and PBS, merge into the main channel. Displacement of blood by the buffer is clearly seen. (The dark lines along the edges are the walls, not remaining blood.) Figure 7 shows the cells and strands of magnetic beads retained by the field after the washing step. The 15 µm diameter size identifies the cells as Jurkats. Counting the captured cells indicated that 450-540 cells were typically captured, corresponding to 40-49% cell capture efficiency for a 2 µl sample delivery, given the loading of Jurkats in the reconstituted blood samples. This result is comparable to those we have reported previously for on-chip, magnetic bead capture, where an external syringe pump [15] was used for pumping.
The captured, purified Jurkat cells were isolated from the microfluidic chip and a polymerase chain reaction (PCR) assay was performed to confirm that they were Jurkat cells. After rinsing with a few microliters of wash buffer the magnet was moved to the exit reservoir, port 1. The blood was removed once it reached port 1. After delivery of 5-6 µl of wash buffer the magnetic beads and the cells were removed from the reservoir with a 10 µl micropipet. This solution was delivered to a PCR tube for DNA amplification. Figure 8 shows a capillary gel electropherogram of the 300 base pair product and a DNA ladder used for calibration. Since hemoglobin inhibits the PCR process, the results illustrate that the captured cells were sufficiently free of red blood cells to allow the assay to occur. The use of magnetic beads provides a very convenient means of localizing the captured cells and transferring them off chip again [22] . The use of PCR provides a powerful amplification of the small quantity of DNA present in the captured cells. We found that the devices could be used 2-6 times before they were plugged by components of the blood samples. Devices exposed to buffers alone could be used until the electrodes delaminated from the glass, which required longer than 30 min at 5 V or 180 µA. These devices would probably be used with a single clinical sample and then disposed, so their current durability is more than adequate.
Conclusions
Our results show that the Twente micro-electrolysis pumps are readily adapted to use with clinically relevant volumes of blood samples, and can be used as part of a sample cleanup procedure. The fluid introduction ports we added to the Twente design provide a very simple way of loading solvents into each zone of the device, and are a useful advance. The results illustrate that the pumps can be used as part of a system, each pump providing the actuation for one element of a number of sample-processing steps. Further improvements in device design are made clear by the current study; our Si passivation procedure needs to be improved, the volume of the electrolysis chamber should be made at least twice as large as the volume of the sample meander to improve pump flow rate stability, and the overall volumes could be increased further to process larger samples. Should the device be manufactured for commercial use, the design could be fabricated in a plastic substrate, eliminating the electrical passivation issue and reducing the cost per device. We anticipate that such devices would be interfaced to downstream immunoassay or genetic assay stages, which might be used multiple times, but that these chips could serve as a front-end sample-preparation stage. Chips could be preloaded with buffers, allowing the user to simply open a port, inject a sample with a pipet, seal the device and turn it on, as we have demonstrated. Automation of the magnetic field changes could clearly be achieved using electromagnets instead of permanent magnets.
